December 17, 2017 | English | عربي
Add to Twitter
 
Ferring Receives Swiss Approval For Rekovelle®, The First Personalised Fertility Treatment Using an Approved Dosing Algorithm
● Rekovelle® provides doctors with an approved, evidence-based, individualised dosing regimen to personalise fertility treatment

● Approval expands options for fertility patients in Switzerland, providing a new and tailored approach to help doctors achieve target ovarian response

● Approval is based on a comprehensive clinical development programme (ESTHER), involving patients in 11 countries and over 2,000 treatment cycles